2011
DOI: 10.1016/j.neuroimage.2011.02.020
|View full text |Cite
|
Sign up to set email alerts
|

Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
64
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 83 publications
(71 citation statements)
references
References 92 publications
7
64
0
Order By: Relevance
“…In this case, quantification was via V T estimated using a metabolite-corrected arterial plasma input function for which, as in the current study, there was a large interindividual variability. In work by Gulyás et al, 40 the SUV of [ 11 C]vinpocetine was found to increase with age in some brain regions, with similar increases found for healthy controls and patients with Alzheimer's disease.…”
Section: Discussionmentioning
confidence: 61%
“…In this case, quantification was via V T estimated using a metabolite-corrected arterial plasma input function for which, as in the current study, there was a large interindividual variability. In work by Gulyás et al, 40 the SUV of [ 11 C]vinpocetine was found to increase with age in some brain regions, with similar increases found for healthy controls and patients with Alzheimer's disease.…”
Section: Discussionmentioning
confidence: 61%
“…More recently, Schuitemaker et al [128] reported an increase in the specific binding of [ 11 C]PK-11195 with aging in healthy subjects (19-79 years old) in several cortical and subcortical areas (frontal cortex, anterior and posterior cingulate cortex, medial inferior temporal lobe, insula, hippocampus, entorhinal cortex, thalamus, parietal and occipital cortex and cerebellum) [128]. Gulyas et al [164] used PET with [ 11 C]vinpocetine, another TSPO radioligand, to study microglial activation during normal brain aging (healthy volunteers aged between 25 and 78 years) and reported increased uptake and binding with age in the entire brain and in all the brain regions studied. The significance of the age-related increase in [ 11 C]PK-11195-specific binding remains undetermined.…”
Section: Discussionmentioning
confidence: 99%
“…However, it has yet to be firmly established whether the microglial activation observed corresponds with amyloid or tau distribution or represents an independent pathologic distribution. Further, other clinical studies have failed to differentiate Alzheimer disease patients from age-matched controls (9,10). This disparity indicates the importance of trialing a variety of radiotracers for appropriate sensitivity and specificity.…”
Section: Second-and Third-generation Tspo Radiotracers In Neurologic mentioning
confidence: 99%